Search Results | Diabetes | American Diabetes Association

1-20 of 33

Sort by

Sort Order Select

Meeting Abstracts

762-P: Use of Oral Hypoglycemic Agents in Type 1 DM

KARINA G. ROMO, WILLIAM A. WEST, GABRIEL I. UWAIFO

Diabetes 2021;70(Supplement_1):762-P

DOI: https://doi.org/10.2337/db21-762-P

Published: 01 June 2021

View article titled, 762-P: Use of Oral Hypoglycemic Agents in Type 1 DM

Meeting Abstracts

1205-P: Diabetes Medical Care Quality Index (ICAD): A Nationwide Experience of Continuous Improvement in Primary Health Care Clinics

HECTOR GALLARDO, LORENA SUAREZ-IDUETA, JULIETA LOMELIN-GASCON, ALEJANDRA MONTOYA, RICARDO MUJICA-ROSALES, ROBERTO C. TAPIA-CONYER, EDUARDO R. SAUCEDO-MARTINEZ

Diabetes 2020;69(Supplement_1):1205-P

DOI: https://doi.org/10.2337/db20-1205-P

Published: 01 June 2020

View article titled, 1205-P: Diabetes Medical Care Quality Index (ICAD): A Nationwide Experience of Continuous Improvement in Primary Health Care Clinics

Meeting Abstracts

698-P: Factors Significantly Associated with Adherence to Diabetes Medications: Findings from a Large Japanese Claims Database

YUTA YAGUCHI, KAZUYA FUJIHARA, TAEKO OSAWA, MASAHIKO YAMAMOTO, MASANORI KANEKO, MASARU KITAZAWA, MAYUKO HARADA, YASUHIRO MATSUBAYASHI, TAKAHO YAMADA, NAUTA YAMANAKA, HIROYASU SEIDA, HIROHITO SONE

Diabetes 2019;68(Supplement_1):698-P

DOI: https://doi.org/10.2337/db19-698-P

Published: 01 June 2019

View article titled, 698-P: Factors Significantly Associated with Adherence to Diabetes Medications: Findings from a Large Japanese Claims Database

Meeting Abstracts

148-LB: Efficacy and Safety of Adding an Oral Hypoglycemic Agent or a GLP-1 Receptor Agonist to Insulin in Patients with Type 1 Diabetes: A Network Meta-analysis

YOON JI KIM, SEUN DEUK HWANG, SOO LIM

Diabetes 2019;68(Supplement_1):148-LB

DOI: https://doi.org/10.2337/db19-148-LB

Published: 01 June 2019

View article titled, 148-LB: Efficacy and Safety of Adding an Oral Hypoglycemic Agent or a GLP-1 Receptor Agonist to Insulin in Patients with Type 1 Diabetes: A Network Meta-analysis

Meeting Abstracts

2336-PUB: Treatment Effectiveness of Glimepiride Alone and in Combination with Other Oral Hypoglycemic Agents: Outcomes from Real Clinical Practice

KRISHNA G. SESHADRI, C.S. DWARAKANATH, R.M. MANIKANDAN, USHA AYYAGARI, T.S. BOOCHANDRAN, SAMBIT DAS, N.K. NARAYANAN, BALAJI JAGANMOHAN, HARINI REDDY, JANA JAYAPRAKASHSAI, SUREKHA TIPPISETTY, VAMSI KRISHNA KOLUKULA, APOLLO SUGAR RESEARCH GROUP

Diabetes 2019;68(Supplement_1):2336-PUB

DOI: https://doi.org/10.2337/db19-2336-PUB

Published: 01 June 2019

View article titled, 2336-PUB: Treatment Effectiveness of Glimepiride Alone and in Combination with Other Oral Hypoglycemic Agents: Outcomes from Real Clinical Practice

Meeting Abstracts

Effectiveness and Safety of Oral Hypoglycemic Agents as Initial Treatment in Comparison to Insulin Injection in Newly Diagnosed Type 2 Diabetes Mellitus

XI CHEN, YUFAN WANG, AIFANG ZHANG, NIAN WANG, NA LI

Diabetes 2018;67(Supplement_1):1240-P

DOI: https://doi.org/10.2337/db18-1240-P

Published: 01 July 2018

View article titled, Effectiveness and Safety of Oral Hypoglycemic Agents as Initial Treatment in Comparison to Insulin Injection in Newly Diagnosed Type 2 Diabetes Mellitus

Meeting Abstracts

Predicting Diabetes in the First Two Years Postpartum among Women with Recent Gestational Diabetes—The Linda-Brasil Study

CRISTINA D. CASTILHOS, RUBEN LADWIG, MICHELE DREHMER, BRUCE B. DUNCAN, CRISTINA FACANHA, MARIA I. SCHMIDT

Diabetes 2018;67(Supplement_1):1447-P

DOI: https://doi.org/10.2337/db18-1447-P

Published: 01 July 2018

View article titled, Predicting Diabetes in the First Two Years Postpartum among Women with Recent Gestational Diabetes—The Linda-Brasil Study

Meeting Abstracts

Economic Evaluation of Dapagliflozin vs. Other Oral Hypoglycemic Drugs in China via Idealized Model

JUAN ZHENG, LU LONG, ZI YE, LULU CHEN

Diabetes 2018;67(Supplement_1):1314-P

DOI: https://doi.org/10.2337/db18-1314-P

Published: 01 July 2018

View article titled, Economic Evaluation of Dapagliflozin vs. Other Oral Hypoglycemic Drugs in China via Idealized Model

Meeting Abstracts

Total Energy Expenditure Evaluated by Doubly Labeled Water Method in Japanese Patients with Diabetes Mellitus—Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study

KEIKO KONDO, KATSUTARO MORINO, SHIGEHO TANAKA, KEIKO FUSE, AKIKO OHI, MIKA KURIHARA, MASAYA SASAKI, FUMINORI KATSUKAWA, HIROSHI MAEGAWA

Diabetes 2018;67(Supplement_1):775-P

DOI: https://doi.org/10.2337/db18-775-P

Published: 01 July 2018

View article titled, Total Energy Expenditure Evaluated by Doubly Labeled Water Method in Japanese Patients with Diabetes Mellitus—Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study

Meeting Abstracts

Insulin Initiation and Concomitant OHA (Oral Hypoglycaemic Agents) in Treatment of Diabetes Mellitus—Results of the Indian Human Insulin Registry (INHIRIT)

VEERANNA KARADI, DILIP PAWAR, SARAH JABEEN, SANDEEP S., SAPTARSHI BOSE, SAGAR P. WAGH, KINGSHUK BHATTACHARJEE, SANTOSH ANAND, SR.

Diabetes 2018;67(Supplement_1):2293-PUB

DOI: https://doi.org/10.2337/db18-2293-PUB

Published: 01 July 2018

View article titled, Insulin Initiation and Concomitant OHA (Oral Hypoglycaemic Agents) in Treatment of Diabetes Mellitus—Results of the Indian Human Insulin Registry (INHIRIT)

Meeting Abstracts

Patient Experience after Being Discharged with Newly Prescribed Insulin or Oral Hypoglycemic Agents

NABIL Z. MADHUN, ELLEN CALOGERAS, SOAMSIRI NIWATTISAIWONG, M. CECILIA LANSANG

Diabetes 2018;67(Supplement_1):2325-PUB

DOI: https://doi.org/10.2337/db18-2325-PUB

Published: 01 July 2018

View article titled, Patient Experience after Being Discharged with Newly Prescribed Insulin or Oral Hypoglycemic Agents

Journal Articles

Metabolite-Regulated ATP-Sensitive K⁺ Channel in Human Pancreatic Islet Cells

Stanley Misler, William M Gee, Kevin D Gillis, David W Scharp, Lee C Falke

Diabetes 1989;38(4):422–427

DOI: https://doi.org/10.2337/diab.38.4.422

Published: 01 April 1989

View article titled, Metabolite-Regulated ATP-Sensitive K<sup>+</sup> Channel in Human Pancreatic Islet Cells

Journal Articles

Studies of Midaglizole (DG-5128): A New Type of Oral Hypoglycemic Drug in Healthy Subjects

S Kawazu, M Suzuki, K Negishi, T Watanabe, J Ishii

Diabetes 1987;36(2):216–220

DOI: https://doi.org/10.2337/diab.36.2.216

Published: 01 February 1987

View article titled, Studies of Midaglizole (DG-5128): A New Type of Oral Hypoglycemic Drug in Healthy Subjects

Journal Articles

Effects of Oral Hypoglycemic Agent Methylpalmoxirate on Exercise Capacity of Streptozocin Diabetic Rats

J C Young, J L Treadway, E I Fader, R F Caslin

Diabetes 1986;35(7):744–748

DOI: https://doi.org/10.2337/diab.35.7.744

Published: 01 July 1986

View article titled, Effects of Oral Hypoglycemic Agent Methylpalmoxirate on Exercise Capacity of Streptozocin Diabetic Rats

Journal Articles

Pirogliride: An Oral Hypoglycemic Drug Which Accelerates Glucose Usage and Insulin Secretion by Islets of Langerhans

Walter S Zawalich, Victoria A Weill, Franz M Matschinsky

Diabetes 1980;29(5):410–412

DOI: https://doi.org/10.2337/diab.29.5.410

Published: 01 May 1980

View article titled, Pirogliride: An Oral Hypoglycemic Drug Which Accelerates Glucose Usage and Insulin Secretion by Islets of Langerhans

Journal Articles

Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively

Gene F Tutwiler, Richard Mohrbacher, Winston Ho

Diabetes 1979;28(3):242–248

DOI: https://doi.org/10.2337/diab.28.3.242

Published: 01 March 1979

View article titled, Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively

Journal Articles

The Effects of Long-term Therapy with Oral Hypoglycemic Agents on the Oral Glucose Tolerance Test Dynamics in Male Chemical Diabetics

M H Tan, MD, C A Graham, MD, R F Bradley, MD, R E Gleason, PhD, J S Soeldner, MD

Diabetes 1977;26(6):561–570

DOI: https://doi.org/10.2337/diab.26.6.561

Published: 01 June 1977

View article titled, The Effects of Long-term Therapy with Oral Hypoglycemic Agents on the Oral Glucose Tolerance Test Dynamics in Male Chemical Diabetics

Journal Articles

The Prognostic Importance of Plasma Glucose Levels and of the Use of Oral Hypoglycemic Drugs After Myocardial Infarction in Men

Coronary Drug Project Research Group

Diabetes 1977;26(5):453–465

DOI: https://doi.org/10.2337/diab.26.5.453

Published: 01 May 1977

View article titled, The Prognostic Importance of Plasma Glucose Levels and of the Use of Oral Hypoglycemic Drugs After Myocardial Infarction in Men

Journal Articles

Experience with Automation as an Aid in the Management of Diabetes

Robert E Bolinger, M.D., Sandra Price, AB, Joseph L Kyner, M.D.

Diabetes 1973;22(6):480–484

DOI: https://doi.org/10.2337/diab.22.6.480

Published: 01 June 1973

View article titled, Experience with Automation as an Aid in the Management of Diabetes

Journal Articles

Labeling of Oral Hypoglycemic Drugs

Diabetes 1972;21(7):833

DOI: https://doi.org/10.2337/diab.21.7.833

Published: 01 July 1972

View article titled, Labeling of Oral Hypoglycemic Drugs

NARROW

762-P: Use of Oral Hypoglycemic Agents in Type 1 DM

1205-P: Diabetes Medical Care Quality Index (ICAD): A Nationwide Experience of Continuous Improvement in Primary Health Care Clinics

698-P: Factors Significantly Associated with Adherence to Diabetes Medications: Findings from a Large Japanese Claims Database

148-LB: Efficacy and Safety of Adding an Oral Hypoglycemic Agent or a GLP-1 Receptor Agonist to Insulin in Patients with Type 1 Diabetes: A Network Meta-analysis

2336-PUB: Treatment Effectiveness of Glimepiride Alone and in Combination with Other Oral Hypoglycemic Agents: Outcomes from Real Clinical Practice

Effectiveness and Safety of Oral Hypoglycemic Agents as Initial Treatment in Comparison to Insulin Injection in Newly Diagnosed Type 2 Diabetes Mellitus

Predicting Diabetes in the First Two Years Postpartum among Women with Recent Gestational Diabetes—The Linda-Brasil Study

Economic Evaluation of Dapagliflozin vs. Other Oral Hypoglycemic Drugs in China via Idealized Model

Total Energy Expenditure Evaluated by Doubly Labeled Water Method in Japanese Patients with Diabetes Mellitus—Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study

Insulin Initiation and Concomitant OHA (Oral Hypoglycaemic Agents) in Treatment of Diabetes Mellitus—Results of the Indian Human Insulin Registry (INHIRIT)

Patient Experience after Being Discharged with Newly Prescribed Insulin or Oral Hypoglycemic Agents

Metabolite-Regulated ATP-Sensitive K⁺ Channel in Human Pancreatic Islet Cells

Studies of Midaglizole (DG-5128): A New Type of Oral Hypoglycemic Drug in Healthy Subjects

Effects of Oral Hypoglycemic Agent Methylpalmoxirate on Exercise Capacity of Streptozocin Diabetic Rats

Pirogliride: An Oral Hypoglycemic Drug Which Accelerates Glucose Usage and Insulin Secretion by Islets of Langerhans

Methyl 2-Tetradecylglycidate, An Orally Effective Hypoglycemic Agent that Inhibits Long Chain Fatty Acid Oxidation Selectively

The Effects of Long-term Therapy with Oral Hypoglycemic Agents on the Oral Glucose Tolerance Test Dynamics in Male Chemical Diabetics

The Prognostic Importance of Plasma Glucose Levels and of the Use of Oral Hypoglycemic Drugs After Myocardial Infarction in Men

Experience with Automation as an Aid in the Management of Diabetes

Labeling of Oral Hypoglycemic Drugs

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only